NIH Program Announcements

  • HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
    (PA-17-278)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard AIDS datess apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)
    (PA-17-279)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
    (PA-17-280)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates .
  • In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
    (PA-17-281)
    National Institute of Allergy and Infectious Diseases
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
    (PA-17-282)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
    (PA-17-283)
    National Institute of Allergy and Infectious Diseases
    Application Receipt/Submission Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates .
  • Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21)
    (PA-17-284)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01)
    (PA-17-285)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp)
    (PA-17-286)
    National Institute of Biomedical Imaging and Bioengineering
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Genomic Community Resources (U24)
    (PAR-17-273)
    National Human Genome Research Institute
    National Cancer Institute
    Application Receipt/Submission Date(s): The first due date is July 13, 2017; Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
    (PAR-17-274)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): July 11, 2017 and then Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)
    (PAR-17-275)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): Standard dates apply by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. This FOA is being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. This FOA will be reissued for additional due date(s) on or after January 25, 2018.
  • NIH StrokeNet Regional Coordinating Stroke Centers (U24)
    (PAR-17-276)
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): September 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01)
(PAR-17-277)
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Applications are accepted by continuous receipt. Council Round Receipt Window January June 11 October 10 May October 11 February 10 October February 10 June 10 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s